Interleukin-2 (IL-2) is a vital cytokine secreted by activated T lymphocytes, and plays an important role in the regulation of cellular functions and immunity of animals. In this study, the recombinant duck IL-2 (rduIL-2) was secretory expressed in Pichia pastoris (P. pastoris). The recombinant P. pastoris strain was cultured in shake flasks and then scaled up in a 5.0-l bioreactor. The result showed that the maximal fresh-cell-weight of 594.1 g/l and the maximal OD 600 of 408 were achieved in the bioreactor. The rduIL-2 was purified by two steps of purification procedures, and approximately 311 mg of rduIL-2/L fermentation supernatant was obtained. SDS-PAGE showed that the purified rduIL-2 constituted a homogeneous band of 16 kDa or ~14 kDa corresponding to the glycosylated or non-glycosylated duIL-2 protein in size, respectively. The bioactivity of rduIL-2 was determined by lymphocyte proliferation assay. The result indicated that the rduIL-2 greatly promoted the proliferation of ConA-stimulated lymphocytes in vitro. The P. pastoris expression system described here could provide promising, inexpensive, and large-scale production of the rduIL-2, which lays the foundation for development of novel immunoadjuvants to enhance both the immunity of ducks against various infectious pathogens and vaccine efficacy.
Interleukin-2 (IL-2) is a vital cytokine that functions as a growth factor and central regulator in the immune system [2] . This cytokine serves as a growth factor for a variety of cell types and plays key roles in T cell growth and differentiation, functional B cell development, and activation of NK cells following stimulation with antigens or mitogens [7] . IL-2 has been used as an enhancing agent in vaccines. Duck IL-2 (duIL-2) also presents similar bioactivity both in vivo and in vitro [15] . However, the bioactivity of IL-2 produced from different species had selectivity; for example, the proliferative response of duck lymphocytes to recombinant chicken IL-2 was only 60% of that seen with recombinant duIL-2 [15] . Therefore, it is necessary to obtain the duck IL-2 production for enhancing the vaccine efficacy of ducks.
IL-2 genes from more than 30 species have been identified since the human IL-2 (hIL-2) gene was first cloned and sequenced in 1983 [13] . In 1997, a cDNA clone encoding chicken interleukin-2 (chIL-2) with homology to mammalian IL-2 was described [12] . Subsequently, Bertram et al. [3] found lymphokines released by duck peripheral blood lymphocytes and spleen cells stimulated with PHA, which was of similar functional homology to chIL-2 in maintaining the lymphocyte proliferation. In 2000, a cDNA sequence of Mallard (ML) duck IL-2 (duIL-2) was deposited in GenBank (GenBank Accession No. AF294323). Recently, a cDNA sequence of Shaoxing (SX) duck IL-2 was cloned and a functionally bioactive recombinant duck IL-2 (rduIL-2) was successfully expressed in E. coli, while monoclonal antibodies (mAbs) and polyclonal antibodies (pAbs) specific for rduIL-2 were generated, which indicated that rduIL-2 has the potential to be used as an immunoadjuvant for enhancing vaccine efficacy [15] .
As is known, it is difficult and costly to directly isolate duIL-2 from natural sources. Therefore, it is necessary to achieve high-yield production of recombinant duIL-2. To date, the gene encoding duIL-2 has been successfully expressed in E. coli, but the rduIL-2 deposited as insoluble inclusion bodies and the recovery of soluble and active rduIL-2 was very low [15] . Pichia pastoris (P. pastoris) has been extensively and widely employed as an excellent eukaryotic expression system for the recombinant expression of functional proteins that came from eukaryotic cells [6] . Therefore, in order to obtain bioactive rduIL-2 of high-level expression, we cloned the duIL-2 gene from Muscovy duck and adopted the P. pastoris GS115 system to produce recombinant duIL-2 in this study. The final results showed that the recombinant duIL-2 possessed high biological activity, which lays the foundation for the preparation of specific recombinant IL-2 protein and the development of novel immunoadjuvants to enhance both the immunity of ducks against various infectious pathogens and vaccine efficacy.
MATERIALS AND METHODS
Strains, Plasmids, Media, and Materials E. coli DH5α was conserved by our laboratory and plasmid pUCm-T-duIL-2 was constructed by our laboratory. P. pastoris expression vector pPIC9K and P. pastoris host strain GS115 were purchased from Invitrogen Co., Shanghai, P. R. China. Recombinant DNA manipulations were carried out in E. coli strain DH5α. DH5α cells were cultured in Luria-Bertani medium [9] at 37 o C. Ampicillin was added to LB medium at the final concentration of 100 µg/ml for plasmid selection. Minimal dextrose (MD) medium, minimal methanol (MM) medium, buffered glycerol complex (BMGY) medium, buffered methanol complex (BMMY) medium, fermentation basal salts (FBS) medium, and PTM1 trace salts solution were prepared according to the instructions for the Pichia Expression Kit [5] . GS115 cells were cultured in either of the above media at 30 o C unless otherwise indicated.
The restriction endonucleases EcoRI, NotI, and SalI, and Taq DNA polymerase and T4 DNA ligase were purchased from Takara, Dalian, P. R. China. The DEAE-Sepharose was purchased from GE. Con A, α-methyl D-mannoside, Roswell Park Memorial Institute 1640 (RPMI 1640) medium, and fetal calf serum (FCS) were purchased from Sigma. The duck splenic mononuclear cells (SMC) were prepared as described by Zhou et al. [15] .
Construction of Plasmid pPIC9K-duIL-2
The vector pPIC9K carries the genes for histidinol dehydrogenase required for selection of the transformants and the a-Factor secretion signal sequence in the downstream of the AOXl promoter for foreign DNA secretion expression in P. pastoris [10] . A cDNA sequence encoding the mature duck IL-2 molecule was generated by PCR using plasmid pUCm-T-duIL-2 as the template and the following primers: forward primer 5'-CGAATTCGCACCTCTATCAGAGAAA-3'(EcoRI site on the 5' end is underlined), and reverse primer 5'-TAGCGGCCGCTTATTTTAGCATAGATC-3'(NotI site on the 5' end is underlined). Both the PCR product (the mature duIL-2 gene) and the plasmid pPIC9K were digested by EcoRI and NotI, and then were ligated at 16 o C overnight. The ligated product was transformed into the competent E. coli DH5α cells and transformants were screened for ampicillin resistance. Plasmid DNA from resistant colonies was confirmed by restriction enzyme digestion and sequencing using 5'/3' AOX primers. The recombinant plasmid containing the mature duIL-2 ORF sequence was named as pPIC9K-duIL-2.
Transformation of P. pastoris and Induced Expression of Recombinant duIL-2
The recombinant plasmid pPIC9K-duIL-2 was linearized with SalI and 10 µg of purified DNA fragment of linearized plasmid pPIC9K-duIL-2 was transformed into the competent P. pastoris GS115 cells by electroporation in a Biorad GenePulser with settings of 1,800 V, 25 µF capacitance, and 400 ohms resistance. Selective culture medium without histamine (MD/His 
Western Blotting Analysis
The expressed proteins were subjected to SDS-PAGE using 15% gel and then blotted to a nitrocellulose membrane (Amersham Pharmacia Biotech, New Jersey, USA) as previously described [14] . The membrane was blocked for 1 h at room temperature with TBST (25 mM Tris-HCl, 125 mM NaCl, 0.1% Tween 20, pH 8.0) containing 5% skimmed milk. After washing five times with TBST, the blots were incubated with anti-duIL-2 polyclonal antibody (1:1,000, produced by our laboratory). After washing three times for 5 min with TBST, the membranes were incubated with horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG (1:5,000; Southern Biotechnology Associates Inc., Birmingham, USA) in TBST containing 5% skimmed milk. DAB (Promega, New Jersey, USA) was added to the corresponding reaction for color development.
High-Density Fermentation
Large-scale fermentation of the recombinant P. pastoris expression strain was performed according to standard procedures [11] , with slight modifications. An overnight culture of the P. pastoris expression strain in 3×100 ml BMGY medium was inoculated into 3.0 l of FBS medium in a 5.0 l fermentation vessel. The initial glycerol batch cultivation (approxomately 15 h) was performed with vigorous agitation (about 500 rpm) while sparging the solution with an air/O 2 mixture to maintain a 40% dissolved oxygen level. The pH of the culture medium was maintained at 5.0 by addition of 5 M NH 4 OH. The temperature was maintained at 28 o C. After the glycerol batch phase was completed (as evidenced by a decreased O 2 requirement at 30% dissolved oxygen level), the glycerol fedbatch phase was started by delivery of 250 ml of 50% glycerol at a rate of 15 ml/h. When the addition was completed, 500 ml of PY medium (containing 8% peptone and 4% yeast extract) was added and recombinant expression was induced by methanol feeding. Filter-sterilized methanol containing 12 ml/l of PTM1 trace metals solution was delivered using a continuous-duty Watson-Marlow peristaltic pump at a constant rate of 15 ml/h for about 3 days. During fermentation, the fresh-cell-weight and OD Purification of the RduIL-2 and Yield Analysis The fermentation supernatant containing recombinant duIL-2 was fractionated with ammonium sulfate between 20% and 80% saturation. The precipitate was dissolved in a minimum volume of 20 mM TrisHCl (pH 8.0) and dialyzed against the same buffer. The dialyzed solution was applied to a DEAE-Sepharose column equilibrated with 20 mM Tris-HCl (pH 8.0). After the column was washed until the absorbance at 280 nm reached the baseline, bound proteins were stepwise eluted at a flow rate of 1.0 ml/min with 0.2 M NaCl, 0.4 M NaCl, 0.6 M NaCl, and 0.8 M NaCl in 20 mM Tris-HCl (pH 8.0), respectively. About 14 kDa and 16 kDa protein fractions were collected and dialyzed against PBS for SDS-PAGE analysis and bioactivity assay. The Coomassie brilliant blue-stained SDS-PAGE was scanned with an UVP White/Ultraviolet transilluminator, and analyzed with software Grab-it 2.5 and Gel-work (UVP) for estimating the purity of recombinant duIL-2. To determine the protein concentration, a BCA assay kit (Promega, USA) was used with BSA (10, 20, 50, 100, 200, 500, 1,000, 1,500, and 2,000 µg/ml) as a standard. All the procedures were carried out at 4 o C.
RduIL-2 Bioactivity Assay
The bioactivity of rduIL-2 was determined by lymphocyte proliferation assay in vitro according to standard procedures [8] , with slight modifications. Briefly, the duck SMC stimulated by ConA for 24 h was incubated in RPMI 1640 medium containing 0.1 M α-methyl Dmannoside (α-MM) for 30 min. Then the cells were applied to Histopaque-1077 (Sigma), and live cells were selected after centrifugation. The enriched viable lymphocytes were resuspended in RPMI 1640 containing 10% FCS and cultured at 1×10 . An SI value of 1.5 or above was defined as the positive criteria of the rduIL-2 bioactivity [15] .
RESULTS

Construction of Plasmid pPIC9K-duIL-2
After the mature duIL-2 gene was subcloned into the pPIC9K vector, the recombinant plasmid pPIC9K-duIL-2 was identified by double enzyme digestion with EcoRI and NotI, and then was sequenced. The sequencing result showed that the ORF and nucleic acid sequence of mature duIL-2 gene were correct (date not shown).
Transformation of P. pastoris and Induced Expression of Recombinant DuIL-2
After reconstruction, the recombinant plasmid pPIC9K-duIL-2 was introduced into P. pastoris by electrotransformation. The yeast transformants were confirmed by PCR. The result showed that in contrast to the negative controls, a DNA band of about 360 bp was observed in each yeast transformants, similar to the positive control (date not shown), which indicated that the mature duIL-2 gene had been integrated into the yeast genome. Later, the recombinant yeast transformants were cultured and induced for expression. SDS-PAGE was used to examine the induced supernatant. Compared with the control, an apparent extra protein band of about 16 kDa was observed in the supernatant of the induced yeast transformants (Fig. 1A) . Western Blotting analysis demonstrated that the recombinant duIL-2 expressed in P. pastoris reacted specifically in immunoblotting with anti-duIL-2 polyclonal antibody (Fig. 1B) . High-Density Fermentation and Purification of the RduIL-2 A 5.0 l fed-batch fermentation was carried out with the recombinant P. pastoris expression strain GS115: pPIC9K-duIL-2 in order to generate sufficient rduIL-2 protein for further analysis. At the end of the fermentation run, the fresh-cell-weight and OD 600 of the expression strains were 594.1 g/l and 408.6, respectively (Fig. 2) .
The recombinant duIL-2 was purified from the fermentation broth by ammonium sulfate fractionation and column chromatography on DEAE-Sepharose (Fig. 3) . The results showed that the rduIL-2 proteins were concentrated by ammonium sulfate between 60% and 80% saturation, and then the 16 kDa rduIL-2 proteins were eluted by 0.2 M NaCl, and the 14 kDa rduIL-2 proteins were eluted by 0.4 M NaCl, during DEAE-Sepharose column chromatography. The protein concentration and purity of the recombinant duIL-2 were determined by the BCA method and densitometric analysis of the SDS-PAGE gel.
As the result, the yield and the purity of the rduIL-2 from the fermentation broth were 311.6 mg/l and 96.1~96.5%, respectively (Table 1) . Fig. 2 . Secretory expression of recombinant duck interleukin-2 in high density P. pastoris fermentation cultures.
The fed-batch fermentation was performed in a laboratory 5.0 l fermentor. Fig. 3 . Purification of the recombinant duck interleukin-2 (rduIL-2). 
In Vitro Proliferation of Lymphocytes Stimulated by RduIL-2
The biological activity of rduIL-2 was tested by in vitro proliferation of duck spleen cells. After the activated duck spleen cells were co-cultured with the serial 2-folds dilutions of the protein preparations containing the expressed rduIL-2 of 16 kDa protein or 14 kDa protein, respectively, the culture mixtures were reacted for 4 h with WST-1. The result revealed that the rduIL-2 exhibited stimulation to proliferation of duck lymphocytes from 6.3 ng rduIL-2/well for the 16 kDa protein and 12.5 ng rduIL-2/well for the 14 kDa protein, and they both maximally stimulated the proliferation at 100 ng rduIL-2/ well (Fig. 4) . The results showed that the glycosylated and non-glycosylated rduIL-2 proteins both possessed biological activity, and the former possessed higher biological activity than the later.
DISCUSSION
Avian influenza is a highly contagious viral disease of major concern to both the poultry industry and human health [1] , and therefore, it is very important to enhance both the immunity of poultries against various infectious pathogens and vaccine efficacy. The application of cytokines as safe, economic, and efficient immunoadjuvants is one of the most promising methods for raising systematic immunity against various infectious pathogens. Interleukin-2 (IL-2) is a vital cytokine secreted by activated T lymphocytes, and plays an important role in the regulation of cellular function and immunity of animals. Recombinant duck IL-2 (rduIL2) has been found to be able to enhance cellmediated immunity in vitro and in vivo [15] , therefore, it is necessary to produce abundant rduIL2 for industrial application.
Our studies indicate that P. pastoris can serve as a suitable expression host for large-scale production of functionally active rduIL-2. Firstly, the P. pastoris expression system involving alcohol oxidase 1 gene regulatory elements has been characterized as one of the most efficient systems among all varieties of yeast, and the gene of interest is integrated into the genome of P. pastoris, and therefore the genome of P. pastoris is more genetically stable than the E. coli expression system [5] . Secondly, the recombinant protein was directed to the extracellular medium, and P. pastoris secretes relatively few of its own proteins. SDS-PAGE showed that the purity of rduIL-2 in the extracellular medium was 67.4% (Table 1) , which dramatically facilitates purification. In contrast, the E. coli-derived rduIL-2 was not secreted by the heterologous host cell. Localized to the cytoplasm, the bacterially produced rduIL-2 requires denaturation and renaturation to recover functional activity [15] . This processing is not only technically demanding, but also costly and may introduce some variability in the product. By comparison, P. pastoris allows for rduIL-2 to be made efficiently and economically. Thirdly, P. pastoris is particularly suitable for the fermentative growth. In this study, we scaled up the production of rduIL-2 from shakeflasks of 20 ml to 3.0 l in a 5.0 l fermentation vessel. At 70 h after induction, the biomass reached the maximum of 594.1 g/l and OD 600 reached 408 (Fig. 2) , and the yield of rduIL-2 reached up to the maximum of 311.6 mg/l (Table 1) , which was more higher than the 3.4 mg/l from the E.coli expression system [15] . Fourthly, in the P. pastoris expression system, the recombinant protein can be glycosylated and possesses higher biological activity. In this study, purified duIL-2 revealed two bands corresponding to the molecular masses of 16 kDa and 14 kDa on SDS-PAGE ( Fig. 3C  and 3D) . A similar observation was found in chicken IL-2, . An SI value of 1.5 or above was defined as the positive criteria of the rduIL-2 bioactivity. and the upper band was the glycosylated form of this protein [4] . The results of Western boltting analysis and lymphocyte proliferation assay showed that the 16 kDa protein was recombinant duIL-2. As the degree of identity for amino acid sequences between duIL-2s and chicken IL-2s was 55.0-56.7%, and the sites of N-glycosylation were included in the conserved domains [15] , the 16 kDa duIL-2 was quite possibly the glycosylated form of this protein. The results indicated that the rduIL-2 greatly promoted the proliferation of ConA-stimulated lymphocytes in vitro, and the 16 kDa duIL-2 possessed higher biological activity than the 14 kDa duIL-2 (Fig. 4) .
In summary, the P. pastoris expression system described here could provide promising, inexpensive, and large-scale production of the recombinant duIL-2, which lays the foundation for development of novel immunoadjuvants to enhance both the immunity of ducks against various infectious pathogens and vaccine efficacy.
